Complete remission of an advanced basal cell carcinoma after only 3-month treatment with sonidegib: Report of a case and drug management during COVID-19 pandemic.

Villani, Alessia; Fabbrocini, Gabriella; Costa, Claudia; Scalvenzi, Massimiliano

Villani, Alessia; Fabbrocini, Gabriella; Costa, Claudia; Scalvenzi, Massimiliano.

Villani A; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Fabbrocini G; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Costa C; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Scalvenzi M; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Dermatol Ther ; 33(6): e14200, 2020 11.

Article in English | MEDLINE | ID: covidwho-793764

Subject(s)

Biphenyl Compounds/therapeutic use; COVID-19/epidemiology; Carcinoma, Basal Cell/drug therapy; Pyridines/therapeutic use; SARS-CoV-2; Skin Neoplasms/drug therapy; Aged; Biphenyl Compounds/pharmacology; Carcinoma, Basal Cell/pathology; Humans; Male; Pyridines/pharmacology; Skin Neoplasms/pathology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pyridines / Skin Neoplasms / Biphenyl Compounds / Carcinoma, Basal Cell / SARS-CoV-2 / COVID-19 Type of study: Case report / Observational study Limits: Aged / Humans / Male Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: Dth.14200

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google